1. Home
  2. CVRX vs OIA Comparison

CVRX vs OIA Comparison

Compare CVRX & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • OIA
  • Stock Information
  • Founded
  • CVRX 2000
  • OIA 1988
  • Country
  • CVRX United States
  • OIA United States
  • Employees
  • CVRX N/A
  • OIA N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • OIA Finance Companies
  • Sector
  • CVRX Health Care
  • OIA Finance
  • Exchange
  • CVRX Nasdaq
  • OIA Nasdaq
  • Market Cap
  • CVRX 337.5M
  • OIA 313.1M
  • IPO Year
  • CVRX 2021
  • OIA N/A
  • Fundamental
  • Price
  • CVRX $13.91
  • OIA $6.58
  • Analyst Decision
  • CVRX Buy
  • OIA
  • Analyst Count
  • CVRX 7
  • OIA 0
  • Target Price
  • CVRX $15.83
  • OIA N/A
  • AVG Volume (30 Days)
  • CVRX 463.4K
  • OIA 97.9K
  • Earning Date
  • CVRX 10-29-2024
  • OIA 01-01-0001
  • Dividend Yield
  • CVRX N/A
  • OIA 4.88%
  • EPS Growth
  • CVRX N/A
  • OIA N/A
  • EPS
  • CVRX N/A
  • OIA N/A
  • Revenue
  • CVRX $47,255,000.00
  • OIA N/A
  • Revenue This Year
  • CVRX $31.78
  • OIA N/A
  • Revenue Next Year
  • CVRX $26.70
  • OIA N/A
  • P/E Ratio
  • CVRX N/A
  • OIA N/A
  • Revenue Growth
  • CVRX 34.38
  • OIA N/A
  • 52 Week Low
  • CVRX $6.40
  • OIA $4.93
  • 52 Week High
  • CVRX $33.14
  • OIA $6.72
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 60.36
  • OIA 45.05
  • Support Level
  • CVRX $13.59
  • OIA $6.55
  • Resistance Level
  • CVRX $15.95
  • OIA $6.66
  • Average True Range (ATR)
  • CVRX 1.13
  • OIA 0.12
  • MACD
  • CVRX -0.09
  • OIA 0.00
  • Stochastic Oscillator
  • CVRX 65.37
  • OIA 52.50

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About OIA Invesco Municipal Income Opportunities Trust

Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.

Share on Social Networks: